Literature DB >> 27772557

Effectiveness of cognitive behavioral therapy for the treatment of fatigue in patients with multiple sclerosis: A systematic review and meta-analysis.

Lizanne Eva van den Akker1, Heleen Beckerman2, Emma Hubertine Collette3, Isaline Catharine Josephine Maria Eijssen2, Joost Dekker4, Vincent de Groot2.   

Abstract

BACKGROUND: Fatigue is a frequently occurring symptom of multiple sclerosis (MS) that limits social participation.
OBJECTIVE: To systematically determine the short and long-term effects of cognitive behavioral therapy (CBT) for the treatment of MS-related fatigue. DATA SOURCES: Pubmed, Cochrane, EMBASE, Psychology and Behavioral Sciences Collection, ERIC, PsychINFO, Cinahl, PsycARTICLES, and relevant trial registers were searched up to February 2016. In addition, references from retrieved articles were examined. STUDY SELECTION: Studies were included if participants had MS, fatigue was a primary outcome measure, the intervention was CBT, and the design was a randomized controlled trial. The search was performed by two independent reviewers, three CBT experts determined whether interventions were CBT. DATA EXTRACTION: Data on patient and study characteristics and fatigue were systematically extracted using a standardized data extraction form. Two independent reviewers assessed risk of bias using the Cochrane Collaboration risk of bias tool. In the event of disagreement, a third reviewer was consulted. DATA SYNTHESIS: Of the 994 identified studies, 4 studies were included in the meta-analysis, comprising 193 CBT-treated patients and 210 patients who underwent a control treatment. Meta-analyses of these studies showed that CBT treatment had a positive short-term effect on fatigue (standardized mean difference [SMD]=-0.47; 95% confidence interval [CI]=-0.88; -0.06; I2=73%). In addition, three studies showed a long-term positive effect of CBT (SMD=-0.30; CI -0.51; -0.08; I2=0%).
CONCLUSIONS: This review found that the use of CBT for the treatment of fatigue in patients with MS has a moderately positive short-term effect. However, this effect decreases with cessation of treatment.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cognitive behavioral therapy; Fatigue; Multiple sclerosis; Systematic review and meta-analysis

Mesh:

Year:  2016        PMID: 27772557     DOI: 10.1016/j.jpsychores.2016.09.002

Source DB:  PubMed          Journal:  J Psychosom Res        ISSN: 0022-3999            Impact factor:   3.006


  25 in total

1.  Positive effects of fampridine on cognition, fatigue and depression in patients with multiple sclerosis over 2 years.

Authors:  Sarah D Broicher; Linard Filli; Olivia Geisseler; Nicole Germann; Björn Zörner; P Brugger; M Linnebank
Journal:  J Neurol       Date:  2018-02-20       Impact factor: 4.849

2.  Cognitive and affective mechanisms of pain and fatigue in multiple sclerosis.

Authors:  Anne Arewasikporn; Aaron P Turner; Kevin N Alschuler; Abbey J Hughes; Dawn M Ehde
Journal:  Health Psychol       Date:  2018-04-19       Impact factor: 4.267

3.  Post stroke intervention trial in fatigue (POSITIF): Randomised multicentre feasibility trial.

Authors:  Gillian Mead; David Gillespie; Mark Barber; Allan House; Steff Lewis; Hannah Ensor; Simiao Wu; Trudie Chalder
Journal:  Clin Rehabil       Date:  2022-07-21       Impact factor: 2.884

4.  Fatigue in the general population: German normative values of the EORTC QLQ-FA12.

Authors:  Andreas Hinz; Joachim Weis; Elmar Brähler; Anja Mehnert
Journal:  Qual Life Res       Date:  2018-06-16       Impact factor: 4.147

5.  Rationale and design of technology assisted stepped collaborative care intervention to improve patient-centered outcomes in hemodialysis patients (TĀCcare trial).

Authors:  Maria-Eleni Roumelioti; Jennifer L Steel; Jonathan Yabes; Kevin E Vowles; Yoram Vodovotz; Scott Beach; Bruce Rollman; Steven D Weisbord; Mark L Unruh; Manisha Jhamb
Journal:  Contemp Clin Trials       Date:  2018-09-09       Impact factor: 2.226

6.  Integrated Imaginative Distention Therapy to Cope with Fatigue. DIMMI SI Study: The First Randomized Controlled Trial in Multiple Sclerosis.

Authors:  Annalisa Sgoifo; Angelo Bignamini; Loredana La Mantia; Maria G Celani; Piero Parietti; Maria A Ceriani; Maria R Marazzi; Paola Proserpio; Lino Nobili; Alessandra Protti; Elio C Agostoni
Journal:  Neurol Ther       Date:  2017-08-09

7.  Cognitive-behavioural therapy (CBT) for renal fatigue (BReF): a feasibility randomised-controlled trial of CBT for the management of fatigue in haemodialysis (HD) patients.

Authors:  Federica Picariello; Rona Moss-Morris; Iain C Macdougall; Sam Norton; Maria Da Silva-Gane; Ken Farrington; Hope Clayton; Joseph Chilcot
Journal:  BMJ Open       Date:  2018-03-08       Impact factor: 2.692

8.  Mobile Technology Use by People Experiencing Multiple Sclerosis Fatigue: Survey Methodology.

Authors:  Kirsten Van Kessel; Duncan R Babbage; Nicholas Reay; Warren M Miner-Williams; Paula Kersten
Journal:  JMIR Mhealth Uhealth       Date:  2017-02-28       Impact factor: 4.773

9.  Effectiveness of Fatigue Management Interventions in Reducing Severity and Impact of Fatigue in People with Progressive Multiple Sclerosis: A Systematic Review.

Authors:  Scott Rooney; Fiona Moffat; Les Wood; Lorna Paul
Journal:  Int J MS Care       Date:  2019 Jan-Feb

10.  Cancer-Related Fatigue in Post-Treatment Cancer Survivors: Theory-Based Development of a Web-Based Intervention.

Authors:  Teresa Corbett; Jane C Walsh; AnnMarie Groarke; Rona Moss-Morris; Eimear Morrissey; Brian E McGuire
Journal:  JMIR Cancer       Date:  2017-07-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.